Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
4.615
-0.305 (-6.20%)
Mar 5, 2026, 12:56 PM EST - Market open
Atossa Therapeutics Stock Forecast
ATOS's stock price has decreased by -57.99% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Atossa Therapeutics stock have an average target of 31.67, with a low estimate of 20 and a high estimate of 40. The average target predicts an increase of 586.24% from the current stock price of 4.62.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 8, 2025.
Analyst Ratings
The average analyst rating for Atossa Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +766.74% | Dec 8, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $38 → $39 | Strong Buy | Maintains | $38 → $39 | +739.65% | Sep 22, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +712.57% | Jun 6, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +333.37% | Jun 5, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $35 → $36 | Strong Buy | Maintains | $35 → $36 | +685.48% | Apr 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.99
from -3.04
EPS Next Year
-4.41
from -3.99
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.94 | -4.18 | |||
| Avg | -3.99 | -4.41 | |||
| Low | -4.01 | -4.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.